1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
CAR MICROGLIA FOR DIFFUSE MIDLINE GLIOMA (DMG) is sponsored by The Lilabean Foundation. This project, led by Dr. Jessica Foster at Children's Hospital of Philadelphia, aims to engineer microglia, the brain's own immune cells, to recognize and attack DMG tumor cells. This new approach seeks to develop CAR microglia that could help the immune system mount a longer-lasting response compared to current CAR T-cell therapies for DMG.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Researchers at Children's Hospital of Philadelphia and similar institutions focused on engineering microglia for DMG immunotherapy. Confirm the full requirements in the official notice before applying.
The current listing shows $30,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
CAR MICROGLIA FOR DIFFUSE MIDLINE GLIOMA (DMG) is funded by The Lilabean Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program